Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Director comp.
Appointed director
CC transcript

ENZO BIOCHEM INC (ENZ) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/21/2021 GN Enzo's Universal AMPICOLLECT™ Used on GENFLEX® Molecular Platform Cleared for Distribution by FDA Under Emergency Use Authorization
03/17/2021 GN ENZO BIOCHEM TO PRESENT AT THE KEYBANC CAPITAL MARKETS' LIFE SCIENCES & MEDTECH INVESTOR FORUM
03/15/2021 GN Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates
03/04/2021 GN Enzo Biochem to Participate in the H.C. Wainwright Global Life Sciences Conference
03/01/2021 GN Enzo Biochem to Report Second Quarter 2021 Financial Results on Monday, March 15
02/03/2021 GN Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin
01/20/2021 GN ENZO BIOCHEM'S BOARD OF DIRECTORS FORMS NEW CORPORATE DEVELOPMENT AND PLANNING & SUCCESSION COMMITTEES
01/04/2021 GN ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR TESTING POOLED SAMPLES ON THREE PLATFORMS INCLUDING COMPANY'S GENFLEX™ PROPRIETARY SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2
12/28/2020 GN ENZO RESPONDS AFTER REVIEWING THE POSITION OF INSTITUTIONAL SHAREHOLDER SERVICES
12/15/2020 GN Enzo Biochem Hosting Key Opinion Leader Call on GENFLEX™ Molecular System for COVID-19 and the Role of Testing in a Post-Vaccine Treatment Environment
12/09/2020 GN Enzo Biochem Reports First Quarter Fiscal 2021 Financial Results and Provides Business Update
12/02/2020 GN Enzo Biochem to Report First Quarter 2021 Financial Results on Wednesday, December 9
11/25/2020 GN ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS
11/18/2020 GN Harbert Discovery Fund Issues Letter to Enzo Biochem Board of Directors
11/18/2020 GN ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS
10/27/2020 GN ENZO BIOCHEM LAUNCHES GOTESTMENOW™ ONLINE PLATFORM FOR CONSUMERS TO DIRECTLY ORDER COVID-19 LABORATORY TESTS
10/13/2020 GN Enzo Biochem Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
10/06/2020 GN Enzo Biochem to Report Fourth Quarter and Fiscal Year 2020 Financial Results on Tuesday, October 13
07/21/2020 GN ENZO BIOCHEM TO PROVIDE ACCESS TO COVID-19 TESTING AT MORE THAN 50 NY PHARMACIES IN COLLABORATION WITH CPESN NY
06/30/2020 GN Enzo Biochem to Provide COVID-19 Testing to Farmingdale State College Staff and Students as They Return to Campus
06/23/2020 GN Enzo Announces Issuance of U.S. Patent for Methods of Treating Liver Cancer Using Proprietary Compound SK1-I
06/08/2020 GN Enzo Biochem Reports Third Quarter 2020 Financial Results
06/03/2020 GN Enzo Biochem to Announce Third Quarter 2020 Financial Results on Monday June 8, 2020
05/20/2020 GN Enzo Biochem Launches Proprietary Test for Detection of Coronavirus SARS-CoV-2 IgG Antibody Under FDA's Emergency Use Authorization
05/12/2020 GN Enzo Announces Issuance of U.S. Patent for Methods of Producing Monoclonal Antibodies Against Osteoporosis Drug Target Sclerostin
04/29/2020 GN Enzo Announces Issuance of U.S. Patent for Methods of Using Proprietary Compound SK1-I in Patients; Exploring Options for Development as a Potential Treatment for COVID-19
04/24/2018 GN Report: Exploring Fundamental Drivers Behind Enzo Biochem, The Hackett Group, Rexford Industrial Realty, Green Plains, United Community Banks, and Encore Capital Group — New Horizons, Emerging Trends, and Upcoming Developments
03/12/2018 BW Enzo Biochem Reports Second Quarter and First Half Results
03/08/2018 BW Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2018 Results Tuesday, March 13, 2018 at 8:30 AM E.T.
12/19/2017 GN Report: Exploring Fundamental Drivers Behind Allstate, Ashford Hospitality Prime, S&P Global, Enzo Biochem, Seres Therapeutics, and HFF — New Horizons, Emerging Trends, and Upcoming Developments
12/07/2017 BW Enzo Biochem Reports Improved First Quarter Results
12/05/2017 BW Enzo Biochem Schedules Teleconference to Discuss First Quarter 2018 Results Friday, December 8, 2017 at 8:30 AM E.T.
09/27/2017 BW Enzo Biochem Reports Increase in Revenues and Profitable Fourth Quarter
09/22/2017 BW Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter 2017 Results Thursday September 28, 2017 at 8:30 AM E.T.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy